Published in Infect Immun on September 01, 2003
Transcriptome profile of Trypanosoma cruzi-infected cells: simultaneous up- and down-regulation of proliferation inhibitors and promoters. Parasitol Res (2007) 0.95
Deficiency of antigen-specific B cells results in decreased Trypanosoma cruzi systemic but not mucosal immunity due to CD8 T cell exhaustion. J Immunol (2015) 0.82
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem (1982) 27.26
Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite. J Immunol (2001) 2.60
Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro. Infect Immun (1994) 2.35
Highly purified glycosylphosphatidylinositols from Trypanosoma cruzi are potent proinflammatory agents. EMBO J (2000) 1.71
Pivotal role of interleukin-12 and interferon-gamma axis in controlling tissue parasitism and inflammation in the heart and central nervous system during Trypanosoma cruzi infection. Am J Pathol (2001) 1.67
beta-Chemokines enhance parasite uptake and promote nitric oxide-dependent microbiostatic activity in murine inflammatory macrophages infected with Trypanosoma cruzi. Infect Immun (1999) 1.44
Glycosylphosphatidylinositol-anchored mucin-like glycoproteins isolated from Trypanosoma cruzi trypomastigotes initiate the synthesis of proinflammatory cytokines by macrophages. J Immunol (1997) 1.39
The cysteine-cysteine family of chemokines RANTES, MIP-1alpha, and MIP-1beta induce trypanocidal activity in human macrophages via nitric oxide. Infect Immun (1998) 1.39
Gastric invasion by Trypanosoma cruzi and induction of protective mucosal immune responses. Infect Immun (1996) 1.27
Type 1 immunity provides optimal protection against both mucosal and systemic Trypanosoma cruzi challenges. Infect Immun (2002) 1.23
Proinflammatory activity of glycosylphosphatidylinositol anchors derived from Trypanosoma cruzi: structural and functional analyses. J Leukoc Biol (2001) 1.21
Involvement of CD4(+) Th1 cells in systemic immunity protective against primary and secondary challenges with Trypanosoma cruzi. Infect Immun (2000) 1.20
Chemokine secretion of human cells in response to Toxoplasma gondii infection. Infect Immun (1999) 1.18
Cruzipain induces both mucosal and systemic protection against Trypanosoma cruzi in mice. Infect Immun (2002) 1.18
Involvement of Trypanosoma cruzi metacyclic trypomastigote surface molecule gp82 in adhesion to gastric mucin and invasion of epithelial cells. Infect Immun (2003) 1.13
Differential mucosal infectivity of different life stages of Trypanosoma cruzi. Am J Trop Med Hyg (1996) 0.99
Expression of trans-sialidase and 85-kDa glycoprotein genes in Trypanosoma cruzi is differentially regulated at the post-transcriptional level by labile protein factors. J Biol Chem (1999) 0.95
Trypanosoma cruzi: a gene family encoding chitin-binding-like proteins is posttranscriptionally regulated during metacyclogenesis. Exp Parasitol (2001) 0.89
Cloning and characterization of the metacyclogenin gene, which is specifically expressed during Trypanosoma cruzi metacyclogenesis. Mol Biochem Parasitol (2001) 0.88
Trypanosoma cruzi: an in vitro cycle of cell differentiation in axenic culture. Exp Parasitol (1988) 0.84
Differential gene expression during Trypanosoma cruzi metacyclogenesis. Mem Inst Oswaldo Cruz (1999) 0.83
Differential glycosylation of epitope-tagged glycoprotein Gp72 during the Trypanosoma cruzi life cycle. Mol Biochem Parasitol (1996) 0.78
Protein synthesis in purified trypo- and epimastigote forms of Trypanosoma cruzi. Acta Trop (1984) 0.78
A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest (1995) 7.68
Colonic epithelial cell lines as a source of interleukin-8: stimulation by inflammatory cytokines and bacterial lipopolysaccharide. Immunology (1994) 7.01
Colonic epithelial cell lines as a source of interleukin-8: stimulation by inflammatory cytokines and bacterial lipopolysaccharide. Immunology (1994) 5.00
Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis. J Clin Invest (1997) 4.51
Epithelial cells as sensors for microbial infection. J Clin Invest (1997) 3.47
Expression and regulation of the human beta-defensins hBD-1 and hBD-2 in intestinal epithelium. J Immunol (1999) 3.39
Differential and regulated expression of C-X-C, C-C, and C-chemokines by human colon epithelial cells. Gastroenterology (1997) 2.37
Apoptosis of human intestinal epithelial cells after bacterial invasion. J Clin Invest (1998) 2.32
NF-kappa B is a central regulator of the intestinal epithelial cell innate immune response induced by infection with enteroinvasive bacteria. J Immunol (1999) 2.23
Regulated production of interferon-inducible T-cell chemoattractants by human intestinal epithelial cells. Gastroenterology (2001) 1.86
Regulated MIP-3alpha/CCL20 production by human intestinal epithelium: mechanism for modulating mucosal immunity. Am J Physiol Gastrointest Liver Physiol (2001) 1.81
Coccoid and spiral Helicobacter pylori differ in their abilities to adhere to gastric epithelial cells and induce interleukin-8 secretion. Infect Immun (1997) 1.71
Infection of human intestinal epithelial cells with invasive bacteria upregulates apical intercellular adhesion molecule-1 (ICAM)-1) expression and neutrophil adhesion. J Clin Invest (1996) 1.69
Cryptosporidium parvum infection of human intestinal epithelial cells induces the polarized secretion of C-X-C chemokines. Infect Immun (1997) 1.58
Chemokine receptor expression by human intestinal epithelial cells. Gastroenterology (1999) 1.53
Expression of the Salmonella virulence plasmid gene spvB in cultured macrophages and nonphagocytic cells. Infect Immun (1993) 1.46
Enteroinvasive bacteria directly activate expression of iNOS and NO production in human colon epithelial cells. Am J Physiol (1998) 1.36
Differential effects of control and antigen-specific T cells on intracellular mycobacterial growth. Infect Immun (2003) 1.35
Expression of Salmonella typhimurium rpoS and rpoS-dependent genes in the intracellular environment of eukaryotic cells. Infect Immun (1996) 1.31
The regulation and functional consequence of proinflammatory cytokine binding on human intestinal epithelial cells. J Immunol (1998) 1.29
Enhancement of innate and cell-mediated immunity by antimycobacterial antibodies. Infect Immun (2005) 1.27
Regulated production of the T helper 2-type T-cell chemoattractant TARC by human bronchial epithelial cells in vitro and in human lung xenografts. Am J Respir Cell Mol Biol (2001) 1.24
Immune responses stimulated by percutaneous and intradermal bacille Calmette-Guérin. J Infect Dis (1996) 1.21
Anatomical route of invasion and protective mucosal immunity in Trypanosoma cruzi conjunctival infection. Infect Immun (2006) 1.20
In vitro measurement of protective mycobacterial immunity: antigen-specific expansion of T cells capable of inhibiting intracellular growth of bacille Calmette-Guérin. Clin Infect Dis (2000) 1.19
Chemokine secretion of human cells in response to Toxoplasma gondii infection. Infect Immun (1999) 1.18
Characterization of candidate live oral Salmonella typhi vaccine strains harboring defined mutations in aroA, aroC, and htrA. Infect Immun (1999) 1.13
Role of alphabeta and gammadelta T cells in the host response to Salmonella infection as demonstrated in T-cell-receptor-deficient mice of defined Ity genotypes. Infect Immun (1997) 1.10
Human hepatocytes express an array of proinflammatory cytokines after agonist stimulation or bacterial invasion. Am J Physiol (1997) 1.10
Intestinal epithelial cell apoptosis following Cryptosporidium parvum infection. Infect Immun (2000) 1.09
Production of MDC/CCL22 by human intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol (2001) 1.07
Human intestinal epithelial cells respond to Cryptosporidium parvum infection with increased prostaglandin H synthase 2 expression and prostaglandin E2 and F2alpha production. Infect Immun (1998) 1.07
Importance of interleukin-10 in genetic susceptibility of mice to Coccidioides immitis. Infect Immun (1998) 1.07
Canarypox vaccines induce antigen-specific human gammadelta T cells capable of interferon-gamma production. J Infect Dis (2001) 0.97
Pathogenesis of Cryptosporidium parvum infection. Microbes Infect (1999) 0.95
The effect of stem cell proliferation regulators demonstrated with an in vitro assay. Blood (1988) 0.95
Immunization and challenge of mice with insect-derived metacyclic trypomastigotes of Trypanosoma cruzi. Parasite Immunol (1990) 0.93
Analysis of host responses to microbial infection using gene expression profiling. Curr Opin Microbiol (2001) 0.92
Cholera toxin and cholera toxin B subunit induce IgA switching through the action of TGF-beta 1. J Immunol (1998) 0.91
IL-8 secreted by epithelial cells invaded by bacteria. Infect Agents Dis (1993) 0.90
Inhibition of epithelial chloride secretion by butyrate: role of reduced adenylyl cyclase expression and activity. Am J Physiol Cell Physiol (2001) 0.89
Synergistic interactions allow colony formation in vitro by murine haemopoietic stem cells. Leuk Res (1990) 0.88
Intranasal vaccinations with the trans-sialidase antigen plus CpG Adjuvant induce mucosal immunity protective against conjunctival Trypanosoma cruzi challenges. Infect Immun (2010) 0.87
[Intramural stenosing tuberculoma of the esophagus]. Schweiz Med Wochenschr (1969) 0.85
Immunoregulatory role of secreted glycoprotein G from respiratory syncytial virus. Virus Res (2001) 0.85
Human intestinal epithelial cells express receptors for platelet-activating factor. Am J Physiol (1999) 0.83
Validated gene expression biomarker analysis for biopsy-based clinical trials in ulcerative colitis. Aliment Pharmacol Ther (2014) 0.79
Immunization of mice with Lactobacillus casei expressing a beta-intimin fragment reduces intestinal colonization by Citrobacter rodentium. Clin Vaccine Immunol (2011) 0.78
CYP2E1 expression in human lymphocytes from various ethnic populations. Alcohol Clin Exp Res (1999) 0.77
Notice of duplicate publication. Gastroenterology (1995) 0.75
[Surgery in the light and shadow of the law]. Praxis (1967) 0.75
[Hiatal hernias]. Praxis (1969) 0.75
[Mid-term results of an European multicentre study involving 728 supra-selective vagotomies (author's transl)]. Chirurgie (1978) 0.75
[Thymectomy in myasthenia gravis]. Helv Chir Acta (1969) 0.75
[Tetanus 1972]. Schweiz Rundsch Med Prax (1972) 0.75
[Indications for surgery in hiatal hernia]. Schweiz Med Wochenschr (1971) 0.75
[Control of quality for proximal selective gastric vagotomy (author's transl)]. Schweiz Rundsch Med Prax (1978) 0.75
[Precancerous conditions. Early diagnosis and carcinoma of the breast]. Schweiz Rundsch Med Prax (1972) 0.75
Experience with preoperative and early postoperative application of hydroxy-coumarins in surgical patients. Prog Surg (1966) 0.75
[Blood and plasma preservatives as carriers of homologous tetanus antitoxin]. Bibl Haematol (1967) 0.75
[Surgical management of peptic ulcer 1981 (author's transl)]. Schweiz Rundsch Med Prax (1982) 0.75
[Recommendations for tetanus prevention published by the German Society for Surgery]. Chirurg (1969) 0.75
[Surgical aspects of malignant tumors in adults]. Praxis (1966) 0.75
[Stenosing abnormal configuration of the duodenum (author's transl)]. Schweiz Rundsch Med Prax (1981) 0.75
[Objectivation of the selective proximal vagotomy (author's transl)]. Schweiz Rundsch Med Prax (1979) 0.75
[Current status of preventive measures in tetanus]. Langenbecks Arch Chir (1969) 0.75
[Antral drainage of 100 cases of vagotomy and pyloroplasty]. Schweiz Med Wochenschr (1968) 0.75
Metabolically active tumors of the pancreas and the duodenum. Aktuelle Probl Chir (1970) 0.75
[Achalasia]. Praxis (1969) 0.75
[Vagotomy in duodenal ulcer]. Schweiz Med Wochenschr (1971) 0.75
[Thymectomy in myasthenia gravis]. Schweiz Med Wochenschr (1974) 0.75
[Use of human anti-tetanus hyperimmunoglobulin]. Schweiz Med Wochenschr (1970) 0.75
[Surgery in the old age (author's transl)]. Schweiz Rundsch Med Prax (1977) 0.75
[Vagotomy 1972]. Schweiz Rundsch Med Prax (1972) 0.75
[Sound surgical procedures for the aged]. Ther Umsch (1981) 0.75
[Prevention and therapy with immunoglobulin SRK]. Helv Chir Acta (1979) 0.75
[Current role of vagotomy in surgery for duodenal ulcer]. Praxis (1967) 0.75
[First experiences with an automatic stapler for intestinal anastomoses]. Chirurg (1980) 0.75
[Jejuno-ileostomy for malignant obesity (author's transl)]. Schweiz Rundsch Med Prax (1978) 0.75
[Indications for surgery in thyroid diseases]. Schweiz Rundsch Med Prax (1973) 0.75
[The selection of drainage operation in subdiaphragmatic vagotomy]. Helv Chir Acta (1968) 0.75
[Value of worthlessness of foreign serum in tetanus prophylaxis]. Monatsschr Unfallheilkd Versicher Versorg Verkehrsmed (1967) 0.75
[Interdisciplinary treatment planning in cancer]. Schweiz Med Wochenschr (1978) 0.75
[Objectivation of the selective proximal vagotomy (author's transl)]. Schweiz Rundsch Med Prax (1979) 0.75
[End-to-end anastomosis using the EEA stapler: recommendations for technical details]. Helv Chir Acta (1980) 0.75
[Treatment of acute cholecystitis]. Schweiz Rundsch Med Prax (1972) 0.75
[Diverticulosis and diverticulitis]. Gastroenterol Fortbildungskurse Prax (1973) 0.75
[Lymph drainage in autoimmune diseases]. Schweiz Rundsch Med Prax (1971) 0.75
[Choice of vagotomy methods in duodenal ulcer]. Helv Chir Acta (1974) 0.75
[Thoracic duct cannulation and determination of temporary parameters of the lymphoid cell cycle: purpose of such studies in man]. Schweiz Rundsch Med Prax (1971) 0.75
[Preparation for surgery]. Praxis (1969) 0.75
[Ulcerative tumors and duodenal ulcer]. Schweiz Med Wochenschr (1969) 0.75